Meetings

Short-term surges in air pollution in New Jersey from the 2023 Canadian wildfires were associated with a higher stroke rate and more serious strokes, according to a preliminary study released March 3, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

People whose drinking water came from newer groundwater had a higher risk of developing Parkinson’s disease than those whose drinking water came from older groundwater, according to a preliminary study released March 2, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting taking place April 18-22, 2026, in Chicago and online. The study does not prove that newer groundwater causes Parkinson’s disease; it only shows an association.

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency department visits and hospitalizations overall, and with less need for medications used to stop and prevent migraine attacks, according to a preliminary study released March 1, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting taking place April 18-22, 2026, in Chicago and online. The people with chronic migraine starting GLP-1 drugs were compared to people with chronic migraine who were starting topiramate, a drug commonly used to prevent migraine.

Increasing numbers of parents are refusing vitamin K shots for their newborns, putting infants at greater risk of avoidable brain injuries, according to a preliminary systematic review released February 26, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting taking place April 18-22, 2026, in Chicago and online. 

Being an early bird, also called a morning person, and being more physically active are associated with lower risks of amyotrophic lateral sclerosis (ALS), according to a preliminary study released February 25, 2026, that will be presented at the American Academy of Neurology’s 78^th Annual Meeting taking place April 18-22, 2026, in Chicago and online.

A thousand times faster than conventional testing, an ion beam approach to qualifying materials for use in the cores of advanced nuclear reactors is advancing through stages of approval by the industry standards organization ASTM. 

The methodology, developed with leadership by University of Michigan Engineering, will be presented at a special event hosted by the Electric Power Research Institute, March 10-11 in Charlotte, North Carolina.